SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $35,665,000 | +5.6% | 365,684 | +0.5% | 1.35% | -10.6% |
| Q4 2014 | $33,765,000 | -18.5% | 363,884 | -39.6% | 1.52% | -13.1% |
| Q3 2014 | $41,429,000 | -23.5% | 602,345 | +16.6% | 1.74% | -24.0% |
| Q2 2014 | $54,123,000 | +40.2% | 516,445 | +11.0% | 2.29% | +44.5% |
| Q1 2014 | $38,593,000 | -19.3% | 465,145 | -37.1% | 1.59% | -23.1% |
| Q4 2013 | $47,828,000 | +60.2% | 739,005 | +56.9% | 2.06% | +43.7% |
| Q3 2013 | $29,854,000 | – | 470,950 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $989,182,000 | 10.10% |
| BB BIOTECH AG | 1,130,476 | $104,897,000 | 3.40% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 80,000 | $7,423,000 | 3.31% |
| Opus Point Partners Management, LLC | 20,002 | $1,856,000 | 1.84% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,847,094 | $356,972,000 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 363,884 | $33,765,000 | 1.52% |
| Cormorant Asset Management, LP | 100,000 | $9,279,000 | 1.43% |
| Tekla Capital Management LLC | 223,020 | $20,694,000 | 0.97% |
| Lamond Capital Partners LLC | 15,390 | $1,428,000 | 0.94% |
| Squarepoint Ops LLC | 6,700 | $622,000 | 0.60% |